Roxborough Cmmnty Acupuncture is categorized under Acupuncturists in Philadelphia, PA and active since 2002.
Roxborough Cmmnty Acupuncture was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Acupuncturists business, which does work in the B2C market, and is classified as a Acupuncturists, under code number 6213990 by the NAICS.
If you are seeking more information, feel free to contact David Schiman, Owner at the company’s single location by writing to 445 Lyceum Avenue, Philadelphia, Pennsylvania PA 19128 or by phoning (267) 417-0147. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Roxborough Cmmnty Acupuncture |
Contact Person: | David Schiman, Owner |
Address: | 445 Lyceum Avenue, Philadelphia, Pennsylvania 19128 |
Phone Number: | (267) 417-0147 |
Website Address: | pavap.org |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Acupuncturists |
SIC Code: | 8049 |
NAICS Code: | 6213990 |
Share This Business: |
Roxborough Cmmnty Acupuncture was started in 2002 to provide professional Acupuncturists under the SIC code 8049 and NAICS code 6213990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact David Schiman, Owner for inquiries that concern Roxborough Cmmnty Acupuncture by calling the company number (267) 417-0147, as your correspondence is most welcome. Additionally, the physical location of the single location of Roxborough Cmmnty Acupuncture can be found at the coordinates 40.032284,-75.215267 as well as the street address 445 Lyceum Avenue in Philadelphia, Pennsylvania 19128.
For its online presence, you may visit Roxborough Cmmnty Acupuncture’s website at pavap.org and engage with its social media outlets through on Twitter and on Facebook.